title: Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.
authors.forename: W D
authors.initials: WD
authors.lastname: Zollinger
authors.forename: J
authors.initials: J
authors.lastname: Boslego
authors.forename: E
authors.initials: E
authors.lastname: Moran
authors.forename: J
authors.initials: J
authors.lastname: Garcia
authors.forename: C
authors.initials: C
authors.lastname: Cruz
authors.forename: S
authors.initials: S
authors.lastname: Ruiz
authors.forename: B
authors.initials: B
authors.lastname: Brandt
authors.forename: M
authors.initials: M
authors.lastname: Martinez
authors.forename: J
authors.initials: J
authors.lastname: Arthur
authors.forename: P
authors.initials: P
authors.lastname: Underwood
mesh_terms: D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D000917:Antibody Formation; D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002677:Chile; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B